Researchers found that older adults, particularly those over 85, are significantly underrepresented in clinical research studies in the UK. An analysis of data from over 455,000 participants revealed that only 3.2% of recruits were in this “oldest old” category. The majority of participants were aged 65 to 74, and there was notable variation in recruitment based on the medical specialty conducting the study. For instance, older adults made up less than 5% of participants in most specialties, and they were less likely to be included in commercial studies.

This finding is crucial for anyone interested in healthy aging. If older adults are not adequately represented in research, the treatments and interventions developed may not be effective or safe for this age group. This could mean that people over 85 might miss out on therapies that could improve their health, such as those for heart failure or Parkinson’s disease. Greater inclusion in clinical trials could lead to better health outcomes, including improved muscle strength, cognitive function, and overall quality of life for older adults.

The study highlights a significant gap in research participation, particularly for older adults. While the data collection methods were robust, the low representation of the oldest adults raises concerns about equity in healthcare. This research is a call to action for both researchers and healthcare providers to prioritize the inclusion of older populations in clinical studies, ensuring that their unique health needs are addressed.

Source: academic.oup.com